Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15
Authors:
- Maria Giulia NiziMNMaria Giulia Nizi
- Mirko M. MaksimainenMMMirko M. Maksimainen
- Sudarshan MurthySMSudarshan Murthy
- Serena MassariSerena Massari
- Juho AlaviuhkolaJAJuho Alaviuhkola
- Sven T. SowaSSSven T. Sowa
- Albert Galera-PratAGAlbert Galera-Prat
- Renata Prunskaite-HyyryläinenRPRenata Prunskaite-Hyyryläinen
- Patricia KornPKPatricia Korn
- Lari LehtiöLLLari Lehtiö
- 19 April 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 237, 114362
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Tankyrase-targeted therapeutics: expanding opportunities in the PARP familyNature Reviews Drug Discovery, 2012
- Homogeneous Screening Assay for Human TankyraseSLAS Discovery, 2012
- REFMAC5 for the refinement of macromolecular crystal structuresActa Crystallographica Section D Structural Biology, 2011
- Integration, scaling, space-group assignment and post-refinementActa Crystallographica Section D Structural Biology, 2010
- Molecular replacement withMOLREPActa Crystallographica Section D Structural Biology, 2009
- Substrate-Assisted Catalysis by PARP10 Limits Its Activity to Mono-ADP-RibosylationMolecular Cell, 2008
- PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformationOncogene, 2005
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- The PARP superfamilyBioEssays, 2004
- An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD+: application to the high-throughput screening of small molecules as potential inhibitorsAnalytical Biochemistry, 2004